MedTrace Logo

A Double-masked, Randomized, Placebo-controlled,Pilot Study of Diquafosol Tetrasodium in Subjects Following Photorefractive Keratectomy (PRK)

NCT01381731 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2015-11-25

No results posted yet for this study

Summary

The objectives of this trial are to:

* Assess the safety and tolerability of diquafosol tetrasodium ophthalmic solution versus placebo following one week of treatment in subjects undergoing photorefractive keratectomy (PRK).
* Evaluate the potential of diquafosol to accelerate corneal wound healing/re-epithelialization following PRK.

Conditions

  • Photorefractive Keratectomy

Interventions

DRUG

diquafosol tetrasodium ophthalmic solution 2%

opthalmic solution 2 drops in each eye QID

DRUG

placebo

opthalmic solution 2 drops in each eye QID

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2005-06-30
Completion
2005-06-30

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01381731 on ClinicalTrials.gov